Werner Seebacher

1.2k total citations
93 papers, 1.1k citations indexed

About

Werner Seebacher is a scholar working on Organic Chemistry, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Werner Seebacher has authored 93 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Organic Chemistry, 39 papers in Public Health, Environmental and Occupational Health and 34 papers in Epidemiology. Recurrent topics in Werner Seebacher's work include Trypanosoma species research and implications (34 papers), Malaria Research and Control (31 papers) and Research on Leishmaniasis Studies (27 papers). Werner Seebacher is often cited by papers focused on Trypanosoma species research and implications (34 papers), Malaria Research and Control (31 papers) and Research on Leishmaniasis Studies (27 papers). Werner Seebacher collaborates with scholars based in Austria, Switzerland and Pakistan. Werner Seebacher's co-authors include Robert Weis, Robert Saf, Olaf Kunert, Nebojša Simić, Reto Brun, Marcel Kaiser, Ferdinand Belaj, Ernst Haslinger, Pascal Mäser and J. Jurenitsch and has published in prestigious journals such as International Journal of Molecular Sciences, Tetrahedron and Molecules.

In The Last Decade

Werner Seebacher

89 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Werner Seebacher Austria 15 558 329 249 208 198 93 1.1k
Jesús G. Dı́az Spain 21 763 1.4× 240 0.7× 507 2.0× 158 0.8× 124 0.6× 96 1.4k
Ângelo da Cunha Pinto Brazil 14 269 0.5× 197 0.6× 187 0.8× 129 0.6× 47 0.2× 29 649
Lai‐King Sy Hong Kong 19 863 1.5× 108 0.3× 248 1.0× 218 1.0× 58 0.3× 29 1.2k
Alexandra Paulo Portugal 24 1.1k 1.9× 526 1.6× 195 0.8× 94 0.5× 32 0.2× 45 1.5k
Khanitha Pudhom Thailand 23 619 1.1× 267 0.8× 260 1.0× 69 0.3× 40 0.2× 77 1.2k
Carmen Lategan South Africa 20 282 0.5× 454 1.4× 190 0.8× 167 0.8× 28 0.1× 27 993
Jean Fotie United States 15 246 0.4× 278 0.8× 172 0.7× 66 0.3× 46 0.2× 37 654
Cleuza C. da Silva Brazil 15 226 0.4× 200 0.6× 180 0.7× 46 0.2× 45 0.2× 34 629
Cecília Maria Alves de Oliveira Brazil 20 398 0.7× 316 1.0× 402 1.6× 23 0.1× 119 0.6× 67 1.1k
Wim van Uden Netherlands 22 933 1.7× 198 0.6× 353 1.4× 229 1.1× 22 0.1× 35 1.4k

Countries citing papers authored by Werner Seebacher

Since Specialization
Citations

This map shows the geographic impact of Werner Seebacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Seebacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Seebacher more than expected).

Fields of papers citing papers by Werner Seebacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Seebacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Seebacher. The network helps show where Werner Seebacher may publish in the future.

Co-authorship network of co-authors of Werner Seebacher

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Seebacher. A scholar is included among the top collaborators of Werner Seebacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Seebacher. Werner Seebacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seebacher, Werner, et al.. (2022). Synthesis and Antiprotozoal Activity of Azabicyclo-Nonane Pyrimidine Hybrids. Molecules. 28(1). 307–307. 3 indexed citations
2.
Seebacher, Werner, Noor ul Amin Mohsin, Marcel Kaiser, et al.. (2020). Preparation of new 1,3-dibenzyl tetrahydropyridinylidene ammonium salts and their antimicrobial and anticellular activities. European Journal of Medicinal Chemistry. 210. 112969–112969. 4 indexed citations
3.
Seebacher, Werner, et al.. (2017). 抗原虫活性を有する7‐クロロキノリン‐4‐アミンの新規誘導体. Bioorganic & Medicinal Chemistry. 25(3). 948. 1 indexed citations
4.
Ahmad, Sarfraz, Werner Seebacher, Marcel Kaiser, et al.. (2016). The antiprotozoal potencies of newly prepared 3-azabicyclo[3.2.2]nonanes. Archives of Pharmacal Research. 39(10). 1391–1403. 4 indexed citations
5.
Seebacher, Werner, Armin Presser, Robert Weis, et al.. (2015). Synthesis of new 4-phenylpyrimidine-2(1 H )-thiones and their potency to inhibit COX-1 and COX-2. European Journal of Medicinal Chemistry. 101. 552–559. 8 indexed citations
6.
Ahmad, Sarfraz, Werner Seebacher, Armin Presser, et al.. (2014). Synthesis and antiprotozoal activities of new 3-azabicyclo[3.2.2]nonanes. Archives of Pharmacal Research. 38(8). 1455–1467. 3 indexed citations
7.
Seebacher, Werner, et al.. (2013). Antiprotozoal activity of bicyclic diamines with a N-methylpiperazinyl group at the bridgehead atom. Bioorganic & Medicinal Chemistry. 21(17). 4988–4996. 5 indexed citations
8.
Seebacher, Werner, et al.. (2011). New N-methylpiperazinyl derivatives of bicyclic antiprotozoal compounds. European Journal of Medicinal Chemistry. 47(1). 510–519. 23 indexed citations
9.
Seebacher, Werner, et al.. (2010). Dialkylaminoalkyl derivatives of bicyclic compounds with antiplasmodial activity. Bioorganic & Medicinal Chemistry. 18(18). 6796–6804. 3 indexed citations
10.
Weis, Robert, Ferdinand Belaj, Marcel Kaiser, et al.. (2009). Synthesis of Novel Diazabicycles and their Antiprotozoal Activities. Australian Journal of Chemistry. 62(9). 1166–1172. 7 indexed citations
11.
Seebacher, Werner, et al.. (2009). Antiplasmodial and antitrypanosomal activity of bicyclic amides and esters of dialkylamino acids. Bioorganic & Medicinal Chemistry. 17(10). 3595–3603. 7 indexed citations
12.
Weis, Robert & Werner Seebacher. (2009). New Bicyclic Amines: Synthesis and SARs of their Action Against the Causative Organisms of Malaria and Sleeping Sickness. Current Medicinal Chemistry. 16(11). 1426–1441. 6 indexed citations
13.
Seebacher, Werner, et al.. (2008). Antiplasmodial and antitrypanosomal activities of aminobicyclo[2.2.2]octyl ω-aminoalkanoates. European Journal of Medicinal Chemistry. 44(2). 736–744. 13 indexed citations
14.
Weis, Robert, et al.. (2008). Synthesis of bicyclic amines and their activities against Trypanosoma brucei rhodesiense and Plasmodium falciparum K 1. Archives of Pharmacal Research. 31(6). 688–697. 9 indexed citations
15.
Seebacher, Werner, et al.. (2007). Epimers of bicyclo[2.2.2]octan-2-ol derivatives with antiprotozoal activity. European Journal of Medicinal Chemistry. 43(4). 800–807. 5 indexed citations
16.
Seebacher, Werner, et al.. (2007). Bicyclo[2.2.2]octyl esters of dialkylamino acids as antiprotozoals. Bioorganic & Medicinal Chemistry. 15(16). 5543–5550. 8 indexed citations
17.
Seebacher, Werner, et al.. (2006). Synthesis of new esters and oximes with 4-aminobicyclo[2.2.2]octane structure and evaluation of their antitrypanosomal and antiplasmodial activities. European Journal of Medicinal Chemistry. 41(8). 970–977. 9 indexed citations
18.
Seebacher, Werner, et al.. (2005). Investigations on the Formation of 4-Aminobicyclo[2.2.2]-octanones. Molecules. 10(3). 521–533. 2 indexed citations
19.
Seebacher, Werner, R. Brun, Marcel Kaiser, Robert Saf, & Robert Weis. (2005). Synthesis and evaluation of the antitrypanosomal and antiplasmodial activities of new 4-aminobicyclo[2.2.2]octane derivatives. European Journal of Medicinal Chemistry. 40(9). 888–896. 15 indexed citations
20.
Seebacher, Werner, et al.. (2004). Antiprotozoal activities of new bicyclo[2.2.2]octan-2-imines and esters of bicyclo[2.2.2]octan-2-ols. European Journal of Pharmaceutical Sciences. 24(4). 281–289. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026